Institute of Chemistry of Rosario (IQUIR, CONICET-UNR), Suipacha 531, Rosario S2002LRK, Argentina; Pharmaceutical Analysis, Department of Organic Chemistry, School of Pharmaceutical and Biochemical Sciences, National University of Rosario, Suipacha 531, Rosario S2002LRK, Argentina.
Institute of Physics, Universidade Federal do Rio Grande do Sul, Av. Bento Gonçalves 9500, Caixa Postal 15051, Barrio Agronomia, Porto Alegre RSCEP91501-970, Brazil.
J Pharm Biomed Anal. 2018 Sep 5;158:461-470. doi: 10.1016/j.jpba.2018.06.019. Epub 2018 Jun 18.
Nimodipine (NIM) is a calcium channel-blocking agent, which in the solid state exhibits two crystalline modifications, Mode I and Mode II. The first one is a racemic mixture, while the second is a conglomerate. Because the drug has poor aqueous solubility and Mode I is twice as soluble as Mode II, the former is widely preferred for the development of pharmaceutical forms. In order to study the effect of thermal stimuli on the behavior of NIM, an analytical method was developed coupling ATR-FTIR spectroscopy to Multivariate Curve Resolution with Alternating Least Squares (MCR-ALS). The method allowed to monitor the transformations of each polymorph, their respective mixtures and commercial samples, during the thermal treatment. It was observed that Mode II experienced changes during the experiments and the chemometric technique provided the abundance profile and the pure spectra of the different species involved. In this way, it was established that Mode II has two transitions, at 116.8 °C and 131.9 °C, which reflect that Mode II is first transformed into Mode I, which then melts. The liquid phase solidifies to give an amorphous (AM) vitreous solid, which does not revert to the crystalline state. The analysis of a commercial sample of NIM exhibited the similar transformations than Mode II; however, a pronounced decrease was noted in the first transition temperature (95 °C), whereas the second remained essentially unchanged (131.6 °C). This could be a result of the presence of mixtures of Mode I and Mode II (0.32:0.68) in the bulk solid, as confirmed by the analysis of a physical mixture of crystals of Modes I and II. Therefore, it was concluded that the developed ATR-FTIR/MCR-ALS method is suitable for the detailed analysis of the crystalline forms of NIM in bulk drug and enables de study of their possible thermally promoted interconversions.
尼莫地平(NIM)是一种钙通道阻滞剂,在固态下表现出两种晶型,即模式 I 和模式 II。前者是外消旋混合物,而后者是胶态混合物。由于该药物的水溶性差,且模式 I 的溶解度是模式 II 的两倍,因此前者在药物制剂的开发中更为常用。为了研究热刺激对 NIM 行为的影响,采用ATR-FTIR 光谱法结合交替最小二乘法多变量曲线分辨(MCR-ALS)建立了一种分析方法。该方法可监测每种多晶型物及其各自混合物和商业样品在热处理过程中的转化。结果表明,模式 II 在实验过程中发生了变化,化学计量技术提供了所涉及不同物质的丰度曲线和纯光谱。由此确定,模式 II 有两个转变,分别在 116.8°C 和 131.9°C,这表明模式 II 首先转化为模式 I,然后熔融。液相固化形成无定形(AM)玻璃状固体,不会再回到结晶状态。对 NIM 商业样品的分析表现出与模式 II 相似的转变;然而,第一转变温度(95°C)明显降低,而第二转变温度(131.6°C)基本不变。这可能是由于块状固体中存在模式 I 和模式 II 的混合物(0.32:0.68),通过对模式 I 和模式 II 晶体的物理混合物的分析得到了证实。因此,结论是所开发的 ATR-FTIR/MCR-ALS 方法适用于 NIM 原料药中晶型的详细分析,并能够研究其可能的热促进互变。